Klow (TB10 + BPC10 + GHK50 + KPV10)
Quad blend combining TB500, BPC 157, GHK-Cu, and KPV for systemic regeneration and anti-inflammatory effects.
How it works
Stacks angiogenesis (BPC/TB), copper-peptide ECM remodelling (GHK-Cu), and α-MSH-derived anti-inflammatory action (KPV) into a single research blend.
Reported benefits
- Multi-pathway recovery target
- Reduces total injection count vs separate vials
Dosage & administration
Research range: reconstitute to deliver 200-500 mcg of each component per dose, daily for 4-6 weeks.
Dosing information is summarised from published clinical and pre-clinical literature for research purposes only and does not constitute medical advice.
Safety & warnings
- Aggregate side-effect profile of all components
- Use under qualified supervision
For research use. Consult a licensed clinician before any human application. Not for use in pregnancy, lactation, or active malignancy without specialist supervision.
Available presentations
80 mg blend
Klow
Box of 10 · $720
Single vial · $1,440
Related guides
BPC 157
A pentadecapeptide derived from human gastric juice with broad regenerative effects in pre-clinical models.
TB500 (Thymosin B4 Acetate)
A synthetic fragment of thymosin β-4 that promotes cell migration, angiogenesis, and tissue repair.
BPC + TB Blend
Combined BPC 157 and TB500 blend used in recovery protocols to overlap angiogenic and cytoskeletal effects.